Brian Fuglestad, Ph.D.
Fuglestad is interested in drug discovery for cancer targets that are traditionally considered undruggable.
Brian Fuglestad, Ph.D., is interested in drug discovery for cancer targets that are traditionally considered undruggable. Using cutting edge atomic resolution methods such as NMR and SAS, these studies promise to open up new classes of protein drug targets to rational drug design. His research will also illuminate disease mechanisms at the atomic scale and will allow avenues of study that have previously been difficult or impossible.
Fuglestad is joining the Department of Chemistry from a postdoctoral position at the University of Pennsylvania’s Perelman School of Medicine in the Department of Biochemistry and Biophysics. In the Wand group at UPenn, he developed a novel drug discovery method and studied proteins under nano-encapsulation conditions.
Before his postdoctoral training, he earned his doctorate in the Komives group at the University of California San Diego in the Department of Chemistry and Biochemistry and a B.S. in biochemistry from Oklahoma State University.